Study Finds Syphilis Treatment During Pregnancy Critical for Good Birth Outcomes
What: Untreated maternal syphilis increases risk of adverse birth outcomes.
Key Line: “Systematic strategies are needed to address gaps in screening and treatment.”
Study Finds Syphilis Treatment During Pregnancy Critical for Good Birth Outcomes
What: Untreated maternal syphilis increases risk of adverse birth outcomes.
Key Line: “Systematic strategies are needed to address gaps in screening and treatment.”
Science reports the entire CDC team behind contraceptive safety guidelines has been ousted.
A major study ties maternal diabetes to neurodevelopmental issues in children.
Trump administration floats baby bonuses, fertility funding, and fertility-focused Fulbrights.
Jess Valenti flags a suspiciously timed study used to attack abortion pill access.
Trump promotes IVF access while cutting the team responsible for tracking it.
Cosmo breaks down Botox alternatives—and why your injector matters most.
Survey shows vast majority of women feel unprepared for menopause.
Researchers call for standardized criteria to assess dangerous placenta conditions.
Syphilis cases surged 80%; treatment gaps tied to stillbirth and NICU stays.
Over a dozen states are considering bills to expand menopause care and insurance coverage.
A former NIH director calls for institutional changes to better prioritize female health.
New research finds minor, temporary changes in menstrual cycle length post-vaccine.
Bladder-leak brand Poise proposes using pads for hormone testing in rural areas.
Cancer incidence among women continues to rise despite overall progress.
Once academic, now viral—this disinfectant may be the most powerful skin-safe cleanser yet.
WBUR spotlights MAP volunteers mailing abortion meds to banned states.
Most menopause-marketed products are rebranded basics—at luxury prices, says Women’s Health investigation.
KFF poll finds strong bipartisan opposition to health spending cuts.
Estrogen’s role in the brain goes far beyond reproduction, NYT reports.
Hormone therapy may lower a genetic heart risk factor, new WHI data suggests.